M V Relling
Overview
Explore the profile of M V Relling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
176
Citations
6233
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Yang W, Wu G, Broeckel U, Smith C, Turner V, Haidar C, et al.
Clin Pharmacol Ther
. 2016 Jun;
100(4):380-8.
PMID: 27311679
We compared whole exome sequencing (WES, n = 176 patients) and whole genome sequencing (WGS, n = 68) and clinical genotyping (DMET array-based approach) for interrogating 13 genes with Clinical...
12.
Park H, Tse S, Yang W, Kelly H, Kaste S, Pui C, et al.
Pharmacogenomics J
. 2016 Feb;
17(2):180-185.
PMID: 26856247
Treatment with glucocorticoids is associated with lower bone mineral density (BMD). We performed a genome-wide association study to analyze interactive effects between genotypes and cumulative dose of prednisone (PD) over...
13.
Kalman L, Agundez J, Appell M, Black J, Bell G, Boukouvala S, et al.
Clin Pharmacol Ther
. 2015 Oct;
99(2):172-85.
PMID: 26479518
This article provides nomenclature recommendations developed by an international workgroup to increase transparency and standardization of pharmacogenetic (PGx) result reporting. Presently, sequence variants identified by PGx tests are described using...
14.
Relling M, McDonagh E, Chang T, Caudle K, McLeod H, Haidar C, et al.
Clin Pharmacol Ther
. 2014 May;
96(2):169-74.
PMID: 24787449
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is associated with development of acute hemolytic anemia (AHA) induced by a number of drugs. We provide guidance as to which G6PD genotypes are associated with...
15.
Pui C, Pei D, Campana D, Cheng C, Sandlund J, Bowman W, et al.
Leukemia
. 2014 May;
28(12):2336-43.
PMID: 24781017
With improved contemporary therapy, we reassess long-term outcome in patients completing treatment for childhood acute lymphoblastic leukemia (ALL) to determine when cure can be declared with a high degree of...
16.
Fernandez C, Stewart E, Panetta J, Wilkinson M, Morrison A, Finkelman F, et al.
Cancer Chemother Pharmacol
. 2014 Apr;
73(6):1307-13.
PMID: 24771103
Purpose: Asparaginase is an essential component of pediatric acute lymphoblastic leukemia (ALL) therapy. However, asparaginase-induced hypersensitivity reactions can compromise its efficacy either by directly influencing the pharmacokinetics of asparaginase or...
17.
Kaste S, Qi A, Smith K, Surprise H, Lovorn E, Boyett J, et al.
Pediatr Blood Cancer
. 2014 Jan;
61(5):885-93.
PMID: 24395288
Background: We sought to improve lumbar spine bone mineral density (LS-BMD) in long-term survivors of childhood acute lymphoblastic leukemia (ALL) using calcium and cholecalciferol supplementation. Procedure: This double-blind, placebo-controlled trial...
18.
Yang J, Lim J, Huang J, Bass J, Wu J, Wang C, et al.
Clin Pharmacol Ther
. 2013 Jul;
94(2):252-9.
PMID: 23820299
Ototoxicity is a debilitating side effect of platinating agents with substantial interpatient variability. We sought to evaluate the association of thiopurine S-methyltransferase (TPMT) and catechol O-methyltransferase (COMT) genetic variations with...
19.
Johnson J, Klein T, Relling M
Clin Pharmacol Ther
. 2013 Apr;
93(5):384-5.
PMID: 23598455
Tricyclic antidepressant (TCA) clinical pharmacogenetic implementation guidelines for CYP2D6 and CYP2C19 genotypes highlight the importance of both genes. However, studies of the combined impact of the two genes are sparse,...
20.
Shuldiner A, Relling M, Peterson J, Hicks J, Freimuth R, Sadee W, et al.
Clin Pharmacol Ther
. 2013 Apr;
94(2):207-10.
PMID: 23588301
No abstract available.